[Invasive pulmonary aspergillosis]

Related Experiment Video

Updated: Oct 19, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

O Morin, P Germaud

    La Revue Du Praticien
    |September 1, 1989
    PubMed

    Insights

    Fungal infections, particularly invasive pulmonary aspergillosis caused by Aspergillus species, pose a significant risk to patients undergoing cytotoxic drug treatments for blood diseases. Early diagnosis and amphotericin B treatment are crucial for better outcomes.

    Area of Science:

    • Mycology
    • Infectious Diseases
    • Hematology

    Context:

    • Modern treatments for blood diseases often involve cytotoxic drugs, increasing patient susceptibility to opportunistic infections.
    • Invasive aspergillosis, a serious fungal infection, is a growing concern in immunocompromised patients.

    Purpose:

    • To highlight the clinical manifestations, diagnostic methods, and treatment strategies for invasive pulmonary aspergillosis in patients with blood diseases.
    • To emphasize the importance of early detection and intervention in managing Aspergillus infections.

    Summary:

    • Invasive pulmonary aspergillosis, often caused by Aspergillus fumigatus and Aspergillus flavus, presents as a challenging complication in patients receiving cytotoxic therapy.
    • Clinical signs may mimic infective pneumonia, with localized radiological findings being common.
    • Diagnosis relies on pathological data, with broncho-alveolar lavage and bronchial brushing offering sensitive and specific results.
    • Treatment primarily involves intravenous amphotericin B, with outcomes improving when initiated early, especially in localized infections.

    Impact:

    • Improved understanding of Aspergillus infections in immunocompromised patients.
    • Guidance on diagnostic approaches and therapeutic interventions.
    • Potential for improved patient outcomes through timely and appropriate management of invasive fungal infections.

    More Related Videos

    Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis09:52

    Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

    Published on: March 9, 2018

    Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung15:01

    Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung

    Published on: September 18, 2021

    Related Concept Videos

    Pneumonia I: Introduction01:30

    Pneumonia I: Introduction

    Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
    Risk Factors
    Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
    Pulmonary Tuberculosis III01:31

    Pulmonary Tuberculosis III

    Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
    The first classification is based on the development of the disease, and it includes the following categories:
    Fungal Phylum Ascomycota01:28

    Fungal Phylum Ascomycota

    Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
    Atypical Pneumonia01:14

    Atypical Pneumonia

    Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
    Cryptococcal Meningitis01:27

    Cryptococcal Meningitis

    Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
    Pneumonia I: Introduction01:29

    Pneumonia I: Introduction

    Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...